The records concern separate monthly disclosures by Kering, Bureau Veritas, Voltalia and Elis, rather than one underlying issuer event. Kering reported 123,420,778 shares as of August 15, 2026, with 176,808,495 theoretical voting rights and 176,006,168 exercisable voting rights. Bureau Veritas reported 453,899,720 shares as of July 31, 2026, with 579,499,017 theoretical voting rights and 569,690,113 exercisable voting rights. Voltalia reported 131,318,716 shares as of July 31, 2026, with 223,626,007 theoretical voting rights and 223,276,805 exercisable voting rights. Elis reported 232,848,588 shares as of July 31, 2026, with 249,643,406 theoretical voting rights and 231,298,229 exercisable voting rights. The disclosures were made under Article 223-16 of the General Regulation of the French Financial Markets Authority, with the Kering, Voltalia and Elis statements also citing Article L. 233-8 of the French Commercial Code.